Kaposi Mor Teaching Hospital
About Kaposi Mor Teaching Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
AOP Orphan Pharmaceuticals AG
3
Shire
2
Amgen
1
Antisoma Research
1
Basilea Pharmaceutica
1
Gilead Sciences
1
Polyphor Ltd.
1
Tracon Pharmaceuticals Inc.
1
Clinical Trials at Kaposi Mor Teaching Hospital
During the past decade, Kaposi Mor Teaching Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients
2006-01-13
2015-12-15
Completed
150
A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.
2007-06-27
2011-05-25
Completed
48
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
2007-06-01
Unknown status
420
Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
2010-07-14
2017-12-05
Completed
792
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
2011-07-01
2017-06-14
Completed
1,232
Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma
2013-03-08
2019-06-12
Terminated
173
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaposi Mor Teaching Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "AOP Orphan Pharmaceuticals AG" with 3 trials
sponsored, "Shire" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Antisoma Research"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaposi Mor Teaching Hospital"
#1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator, "PharmaEssentia Corporation (Co-Sponsor for USA)" with 1 trials as a collaborator and "PharmaEssentia Corporation (for the U.S.)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Kaposi Mor Teaching Hospital
According to Clinical.Site data, the most researched conditions in "Kaposi Mor Teaching Hospital" are
"Polycythemia Vera" (3 trials), "Acute Bacterial Skin and Skin Structure Infections" (1 trials), "Basal Cell Carcinoma" (1 trials), "Colorectal Cancer" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Kaposi Mor Teaching Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kaposi Mor Teaching Hospital
Most popular intervention types in "Kaposi Mor Teaching Hospital" are "Drug" (15 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Hydroxyurea" (2 trials), "Amonafide and Cytarabine" (1 trials), "Anagrelide" (1 trials) and "Axitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaposi Mor Teaching Hospital
The vast majority of trials in "Kaposi Mor Teaching Hospital" are
16 trials for "All" genders.
Clinical Trials Status at Kaposi Mor Teaching Hospital
Currently, there are NaN active trials in "Kaposi Mor Teaching Hospital".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Kaposi Mor Teaching Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Kaposi Mor Teaching Hospital, 2 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".